As of May 22, 2025, Chemesis International Inc has a Discounted Cash Flow (DCF) derived fair value of $0.00 per share. With the current market price at $0.19, this represents a potential upside of -583.9%.
Key Metrics | Value |
---|---|
DCF Fair Value (5-year) | $0.00 |
DCF Fair Value (10-year) | $0.00 |
Potential Upside (5-year) | -594.0% |
Potential Upside (10-year) | -583.9% |
Discount Rate (WACC) | 5.9% - 9.1% |
Fiscal Year | Revenue (USD millions) | Growth |
---|---|---|
06-2022 | 0 | 5% |
06-2023 | 0 | 5% |
06-2024 | 0 | 2% |
06-2025 | 0 | 4% |
06-2026 | 0 | 2% |
06-2027 | 0 | 2% |
06-2028 | 0 | 6% |
06-2029 | 0 | 5% |
06-2030 | 0 | 2% |
06-2031 | 0 | 7% |
06-2032 | 0 | 2% |
Net profit margin is expected to improve from -860% in 06-2022 to -36% by 06-2032, driven by operational efficiency and economies of scale.
Fiscal Year | Net Profit (USD millions) | Profit Margin |
---|---|---|
06-2022 | (0) | -860% |
06-2023 | (0) | -26% |
06-2024 | (0) | -27% |
06-2025 | (0) | -28% |
06-2026 | (0) | -28% |
06-2027 | (0) | -29% |
06-2028 | (0) | -30% |
06-2029 | (0) | -32% |
06-2030 | (0) | -33% |
06-2031 | (0) | -35% |
06-2032 | (0) | -36% |
. Projected CapEx is expected to maintain at approximately 1412% of revenue.
Depreciation is based on an average useful life of 5 years for capital assets.
Fiscal Year | D&A (USD millions) |
---|---|
06-2023 | 0 |
06-2024 | 0 |
06-2025 | 0 |
06-2026 | 0 |
06-2027 | 0 |
06-2028 | 0 |
Net working capital is expected to increase gradually, with projected changes affecting free cash flow.
Components | Average Days |
---|---|
Days Receivables | 1,929 |
Days Inventory | 125 |
Days Payables | 0 |
Fiscal Year | EBITDA | Tax | CapEx | Change in NWC | FCF |
---|---|---|---|---|---|
2023 | (1) | (0) | 0 | (0) | (2) |
2024 | (1) | (0) | 0 | 0 | (2) |
2025 | (1) | (0) | 0 | 0 | (2) |
2026 | (1) | (0) | 0 | (0) | (2) |
2027 | (1) | (0) | 0 | 0 | (2) |
Valuation Method | Fair Price (USD) | Potential Upside |
---|---|---|
5-Year DCF (Growth) | 0.00 | -594.0% |
10-Year DCF (Growth) | 0.00 | -583.9% |
5-Year DCF (EBITDA) | 0.00 | -100.0% |
10-Year DCF (EBITDA) | 0.00 | -100.0% |
Is Chemesis International Inc (CSI.CN) a buy or a sell? Chemesis International Inc is definitely a sell. Based on our DCF analysis, Chemesis International Inc (CSI.CN) appears to be overvalued with upside potential of -583.9%. The company's strong projected growth in revenue and profitability, coupled with consistent capital expenditure, supports our positive outlook on its intrinsic value.
Key investment drivers include:
Investors should consider reducing exposure at the current market price of $0.19.